395 related articles for article (PubMed ID: 21648190)
21. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
Rostom SA
Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
25. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
Liu Y; Zhang C; Zhang H; Li M; Yuan J; Zhang Y; Zhou J; Guo H; Zhao L; Du Y; Wang L; Ren L
Eur J Med Chem; 2015 Mar; 93():142-55. PubMed ID: 25668494
[TBL] [Abstract][Full Text] [Related]
27. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
[TBL] [Abstract][Full Text] [Related]
28. Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase.
Gangjee A; Jain HD; Kisliuk RL
Bioorg Med Chem Lett; 2005 May; 15(9):2225-30. PubMed ID: 15837298
[TBL] [Abstract][Full Text] [Related]
29. New synthesis of two tridentate bipyrazolic compounds and their cytotoxic activity tumor cell lines.
El Kodadi M; Benamar M; Ibrahim B; Zyad A; Malek F; Touzani R; Ramdani A; Melhaoui A
Nat Prod Res; 2007 Sep; 21(11):947-52. PubMed ID: 17691042
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives.
Nassar IF; El Farargy AF; Abdelrazek FM; Ismail NSM
Nucleosides Nucleotides Nucleic Acids; 2017 Apr; 36(4):275-291. PubMed ID: 28323527
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
[TBL] [Abstract][Full Text] [Related]
33. Novel antitumor acetamide, pyrrole, pyrrolopyrimidine, thiocyanate, hydrazone, pyrazole, isothiocyanate and thiophene derivatives containing a biologically active pyrazole moiety.
Alqasoumi SI; Ghorab MM; Ismail ZH; Abdel-Gawad SM; El-Gaby MS; Aly HM
Arzneimittelforschung; 2009; 59(12):666-71. PubMed ID: 20108654
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.
Koca M; Servi S; Kirilmis C; Ahmedzade M; Kazaz C; Ozbek B; Otük G
Eur J Med Chem; 2005 Dec; 40(12):1351-8. PubMed ID: 16129517
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, antiamoebic activity and cytotoxicity of new pyrazolo[3, 4-d]pyrimidine-6-one derivatives.
Hayat F; Salahuddin A; Azam A
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):472-9. PubMed ID: 21054147
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
37. 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity.
Abbas SE; Aly EI; Awadallah FM; Mahmoud WR
Chem Biol Drug Des; 2015 May; 85(5):608-22. PubMed ID: 25318985
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity relationship studies of pyrazole-based heterocycles as antitumor agents.
Farag AM; Mayhoub AS; Eldebss TM; Amr AG; Ali KA; Abdel-Hafez NA; Abdulla MM
Arch Pharm (Weinheim); 2010 Jul; 343(7):384-96. PubMed ID: 20397210
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]